Detalhe da pesquisa
1.
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Clin Infect Dis
; 76(2): 201-209, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36196614
2.
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Lancet
; 399(10319): 36-49, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883053
3.
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Clin Exp Immunol
; 211(3): 280-287, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729167
4.
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Lancet
; 398(10304): 981-990, 2021 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480858
5.
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Lancet
; 398(10303): 856-869, 2021 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370971
6.
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Lancet
; 396(10267): 1979-1993, 2021 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33220855
7.
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR.
J Clin Microbiol
; 60(4): e0228321, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35321556
8.
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Lancet
; 396(10249): 467-478, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702298
9.
CoronaVac: more data for regulators and policy makers.
Lancet
; 398(10296): 186-188, 2021 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34246359
10.
Identification of antigen-specific B cell receptor sequences using public repertoire analysis.
J Immunol
; 194(1): 252-261, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25392534
11.
BCR repertoire sequencing: different patterns of B-cell activation after two Meningococcal vaccines.
Immunol Cell Biol
; 93(10): 885-95, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25976772
12.
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.
Vaccine
; 42(7): 1445-1453, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036392
13.
Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort.
BMJ Open
; 13(11): e072938, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963701
14.
Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.
BMJ Open
; 13(5): e068966, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37225278
15.
Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland.
Lancet Microbe
; 4(11): e863-e874, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37783221
16.
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
J Infect
; 86(6): 574-583, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37028454
17.
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
EBioMedicine
; 81: 104128, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35779491
18.
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.
JCI Insight
; 7(7)2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192543
19.
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.
Lancet Respir Med
; 10(11): 1049-1060, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690076
20.
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial.
JAMA Netw Open
; 4(10): e2128652, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636914